NMDA and AMPA receptors are both channels in the brain that open in response to glutamate, the nervous system’s main excitatory signaling molecule, but they differ in almost every detail that matters: what it takes to open them, how fast they operate, which ions they let through, and the roles they play in learning, memory, and disease. In practical terms, AMPA receptors handle the fast, moment-to-moment electrical signaling between neurons, while NMDA receptors act as coincidence detectors that trigger longer-lasting changes in how strongly two neurons communicate. Understanding how these two receptors divide labor explains a surprising amount about how the brain learns, why strokes cause lasting damage, and how drugs like ketamine can rapidly lift depression.
What It Takes to Open Each Channel
AMPA receptors are the simpler of the two. When glutamate arrives at a synapse, it binds to AMPA receptors, and the channels snap open within about a millisecond. That fast opening generates the initial jolt of electrical current that drives routine brain signaling. One glutamate molecule binding a single subunit is enough to start the process, though more binding sites being occupied produces a stronger response.
NMDA receptors are pickier. Glutamate alone is not enough. The channel also requires a second molecule, called a co-agonist, to bind a separate site. For years, that co-agonist was assumed to be glycine, but D-serine turns out to be even more potent at the site and is the dominant co-agonist in many brain regions.1PubMed. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor Both glycine and D-serine can fill this role depending on the brain region.2PubMed Central. Differential regulation of NMDA receptors by d-serine and glycine in mammalian spinal locomotor networks But even with both glutamate and a co-agonist bound, the channel still won’t conduct current unless a third condition is met: the neuron’s membrane must already be partially depolarized. That three-part requirement is what makes NMDA receptors so distinctive.
The Magnesium Block and Why It Matters
The reason NMDA receptors demand depolarization is a magnesium ion sitting inside the channel pore at resting voltage. At a neuron’s normal resting state, a magnesium ion plugs the NMDA channel like a cork, blocking current flow even when glutamate and the co-agonist are both bound. Only when the surrounding membrane becomes sufficiently depolarized, usually because nearby AMPA receptors have already fired, does the magnesium get pushed out and allow ions to flow.3PubMed Central. Magnesium acts as a second messenger in the regulation of NMDA receptor mediated CREB signaling in neurons
This voltage-dependent block turns the NMDA receptor into a coincidence detector. It opens only when two things happen at roughly the same time: the presynaptic neuron releases glutamate, and the postsynaptic neuron is already electrically active. That dual requirement is considered critical for associative memory, because it ensures that NMDA channels respond specifically to inputs that arrive when a neuron is already engaged, not to stray signals.3PubMed Central. Magnesium acts as a second messenger in the regulation of NMDA receptor mediated CREB signaling in neurons AMPA receptors have no such block. They open the moment glutamate binds, regardless of what voltage the membrane happens to be at.
Which Ions Get Through
Both receptors let sodium and potassium flow through, which is how they generate electrical signals. The key difference is calcium. NMDA receptors are highly permeable to calcium ions, and it is this calcium influx that triggers most of the downstream biochemical events linked to learning and memory. Calcium acts as an intracellular messenger, activating enzymes and gene-expression programs that can remodel the synapse for hours, days, or longer.
AMPA receptors, by contrast, typically pass very little calcium. The reason comes down to a single molecular edit. Most AMPA receptors in the adult brain contain a subunit called GluA2 that has undergone RNA editing at a specific site, swapping in a positively charged amino acid (arginine) that repels calcium. Simulations show that introducing arginine into even one of the four subunits cuts calcium and potassium conductance substantially, and putting arginine in two subunits essentially abolishes calcium flow through the channel.4bioRxiv. Atomistic Mechanisms of Calcium Permeation Modulated by Q/R Editing and Selectivity Filter Mutations in GluA2 AMPA Receptors In certain neurons, however, AMPA receptors that lack edited GluA2 subunits do permit calcium entry, and these calcium-permeable AMPA receptors play specialized roles in plasticity and are implicated in some disease processes.
Speed, Kinetics, and Desensitization
AMPA receptors are built for speed. They open within about a millisecond of glutamate binding and close almost as quickly once glutamate dissociates. This makes them the workhorse of fast excitatory transmission. However, AMPA receptors also desensitize rapidly: even while glutamate is still bound, the channel can close and enter a non-conducting state. Research shows that occupancy of just a single subunit is enough to trigger desensitization, and channels with anywhere from one to four glutamate molecules bound enter this desensitized state at similar rates.5PubMed Central. How AMPA receptor desensitization depends on receptor occupancy Recovery from desensitization follows a sigmoid time course when multiple subunits are occupied, but is faster and exponential when only one subunit has glutamate bound.5PubMed Central. How AMPA receptor desensitization depends on receptor occupancy
NMDA receptors operate on a much slower timescale. They take longer to open, and once open, they stay conducting for tens to hundreds of milliseconds. This prolonged opening is part of what allows so much calcium to enter the cell. NMDA receptors do desensitize as well, but by different mechanisms, including a calcium-dependent form where the very calcium that enters through the channel feeds back to reduce its activity. The net result is that at any given synapse, AMPA receptors produce a brief, sharp electrical signal, while NMDA receptors contribute a slower, longer-lasting current that rides on top of it.
Their Partnership in Synaptic Plasticity
NMDA and AMPA receptors do not work independently. They cooperate in a system where NMDA receptors detect when a connection needs to be strengthened or weakened, and AMPA receptors carry out the change. This is the basis of synaptic plasticity, the cellular mechanism most closely linked to learning and memory.
During long-term potentiation (LTP), when a synapse is being strengthened, the sequence works like this: strong stimulation depolarizes the postsynaptic neuron enough to relieve the magnesium block, NMDA receptors open and let calcium flood in, and that calcium triggers a signaling cascade that results in more AMPA receptors being inserted into the synapse.6PubMed Central. NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD) The extra AMPA receptors make the synapse more responsive to future glutamate release, effectively turning up the volume on that connection. Studies in hippocampal slices show that most of the new AMPA receptors arrive by sliding along the surface of the dendritic spine from nearby extrasynaptic pools, with additional receptors being delivered from intracellular stores to replenish the surface supply.7PubMed Central. AMPA receptor incorporation into synapses during LTP: the role of lateral movement and exocytosis
Long-term depression (LTD), the weakening of a synapse, uses the same basic architecture in reverse. Lower, more prolonged calcium signals through NMDA receptors activate a different set of enzymes that pull AMPA receptors out of the synapse via internalization. Research in the amygdala has shown that blocking NMDA receptors entirely prevents LTD and the associated removal of surface AMPA receptors. More specifically, NMDA receptors containing the GluN2B subunit appear to be the predominant pathway for triggering AMPA receptor internalization during LTD, whereas receptors containing GluN2A subunits are less involved.8PubMed. GluN2B subunits of the NMDA receptor contribute to the AMPA receptor internalization during long-term depression in the lateral amygdala of juvenile rats
So the division of labor is clean: NMDA receptors decide whether a synapse gets stronger or weaker based on the pattern and magnitude of calcium entry, and AMPA receptors are the effectors whose numbers at the synapse change to implement that decision.
Silent Synapses and How the Brain Wires Itself
Early in brain development, many synapses contain NMDA receptors but no AMPA receptors. These are called “silent synapses” because at normal resting voltages, with the magnesium block in place, they produce no detectable electrical response to glutamate. They exist structurally but are functionally mute during typical low-frequency activity.
Silent synapses are essentially connections waiting to be switched on. When the right pattern of activity comes along, NMDA receptors on these synapses open and let calcium in, which recruits AMPA receptors to the site. This process can happen rapidly, within minutes of NMDA receptor activation by spontaneous synaptic activity, converting a silent synapse into a functional one.9PubMed Central. Activation of silent synapses by rapid activity-dependent synaptic recruitment of AMPA receptors In parallel, the frequency of small spontaneous AMPA-mediated currents increases, confirming that new AMPA receptors are appearing at previously empty sites.9PubMed Central. Activation of silent synapses by rapid activity-dependent synaptic recruitment of AMPA receptors
This mechanism is thought to be central to how neural circuits are sculpted during critical periods of development. The brain overproduces synaptic connections, most of them silent, and experience-driven activity determines which ones get AMPA receptors and become permanent. Silent synapses are less common in the adult brain but have not disappeared entirely, and their reactivation may play a role in adult learning as well.
When Things Go Wrong
Because NMDA and AMPA receptors sit at the core of excitatory signaling, dysfunction in either one has outsized consequences. Several distinct disease processes illustrate this.
Excitotoxicity After Stroke
During a stroke or cardiac arrest, the brain’s blood supply drops, starving neurons of oxygen and glucose. Without energy, cells can no longer maintain their ion gradients, membranes depolarize, and glutamate floods the extracellular space. The sustained presence of glutamate locks both AMPA and NMDA receptors in an open state, but the damage is driven primarily by massive calcium entry through NMDA receptors. The excess calcium activates destructive enzymes, generates free radicals, and triggers cell death in a process called excitotoxicity.10Frontiers in Cellular Neuroscience. Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells This vicious cycle, where calcium overload causes more glutamate release which causes more calcium overload, is a major reason why the brain damage from stroke extends well beyond the area that initially lost blood supply.
NMDA Receptor Hypofunction in Schizophrenia
In schizophrenia, the problem may be the opposite: too little NMDA activity rather than too much. The NMDA hypofunction hypothesis holds that underperforming NMDA receptors on specific inhibitory neurons, particularly parvalbumin-positive interneurons in the cortex, disrupt the balance between excitation and inhibition. Preclinical models using mice with reduced NMDA function in these interneurons during early postnatal life develop behavioral and cognitive features that resemble schizophrenia.11PubMed Central. The origin of NMDA receptor hypofunction in schizophrenia This fits with the observation that drugs which block NMDA receptors, like PCP and ketamine at high doses, can produce psychotic-like symptoms in healthy people.
Anti-NMDA Receptor Encephalitis
A more recently identified condition, anti-NMDA receptor encephalitis, occurs when the immune system produces antibodies against NMDA receptors. The antibodies cause a progressive loss of surface NMDA receptors, leading to severe psychiatric symptoms, seizures, and cognitive decline.12PubMed Central. Molecular Pathogenesis of Anti-NMDAR Encephalitis It often begins with personality changes and psychosis, which can initially be misdiagnosed as a psychiatric illness, before progressing to movement disorders and reduced consciousness. With early immunotherapy, many patients recover substantially, which in itself demonstrates how reversible NMDA receptor loss can be when the underlying cause is addressed.
Drugs That Target Each Receptor
The distinct properties of NMDA and AMPA receptors make each an attractive drug target, but the pharmacological strategies differ considerably.
Ketamine and Depression
Ketamine is an NMDA receptor blocker that has drawn enormous attention for producing rapid antidepressant effects, often within hours, in patients with treatment-resistant depression.13PubMed Central. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine The effects can persist for up to a week or two after a single low dose.14PubMed. Synaptic mechanisms underlying rapid antidepressant action of ketamine The mechanism, paradoxically, involves boosting excitatory signaling. By blocking NMDA receptors on inhibitory interneurons, ketamine reduces their tonic release of the inhibitory neurotransmitter GABA, which disinhibits excitatory neurons. The resulting burst of glutamate activity activates downstream pathways that increase dendritic spine formation and promote synaptic growth in the prefrontal cortex and hippocampus.15Neuropsychopharmacology. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms In rodent models, ketamine rapidly increases levels of brain-derived neurotrophic factor (BDNF) in these regions and enhances new neuron formation in the hippocampus.13PubMed Central. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Memantine and Alzheimer’s Disease
Memantine takes a gentler approach to NMDA blockade. It is a moderate-affinity, voltage-dependent NMDA channel blocker with fast binding and unbinding kinetics.16PubMed. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system–too little activation is bad, too much is even worse The idea is that in Alzheimer’s disease, chronic low-level glutamate noise keeps NMDA receptors partially active, creating a kind of background static that interferes with the normal signal-to-noise ratio neurons need to encode memories. Memantine’s fast kinetics mean it blocks this tonic, pathological activation but gets pushed out of the channel quickly enough to allow the stronger, brief bursts of glutamate that carry meaningful signals to get through. Studies on human NMDA receptors have confirmed this voltage-dependent blocking profile, with memantine showing strong voltage sensitivity and rapid unblocking when the membrane depolarizes normally.17PubMed. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors The clinical benefit is modest, but the underlying logic, that both too much and too little NMDA activation are harmful, captures something real about how the system works.
AMPA Receptor Potentiators
On the AMPA side, a class of compounds sometimes called “ampakines” or positive allosteric modulators works by slowing down AMPA receptor deactivation, keeping the channel open longer after glutamate binds. Crystal structures of these compounds bound to the AMPA receptor show that they wedge into the interface between paired subunits and stabilize the glutamate-bound conformation of the receptor’s clamshell-shaped binding domain.18PubMed Central. Mechanism of positive allosteric modulators acting on AMPA receptors The net effect is stronger, longer-lasting AMPA currents. These compounds have been explored for cognitive enhancement and as potential treatments for depression and neurodegenerative disease, though none has yet achieved wide clinical use. The appeal is intuitive: if synaptic weakening underlies cognitive decline, making AMPA receptors more responsive could help compensate.
Auxiliary Proteins That Reshape AMPA Receptor Behavior
AMPA receptors in living neurons rarely function alone. They associate with auxiliary proteins, most notably a family called TARPs (transmembrane AMPA receptor regulatory proteins), that fundamentally change how the receptor behaves. TARPs influence how many AMPA receptors reach the cell surface, how fast they desensitize, how strongly they respond to glutamate, and even which ions they let through.
The best-studied TARP, called γ2 (or stargazin), illustrates the point. Recent structural work has shown that a specific disulfide bond in the extracellular loop of γ2 is crucial for its ability to enhance AMPA receptor function. When that bond is disrupted, fewer receptors reach the surface and a greater fraction of those that do reach it sit in a desensitized state, reducing the synapse’s overall responsiveness.19Nature Communications. Structure of transmembrane AMPA receptor regulatory protein subunit γ2 NMDA receptors have their own set of regulatory partners, but the TARP system for AMPA receptors is especially elaborate, reflecting the fact that adjusting AMPA receptor number and behavior is the primary way the brain tunes synaptic strength on a moment-to-moment basis.
Shared Architecture, Different Packing
Despite all their functional differences, NMDA and AMPA receptors are structurally related. Both are built from four subunits arranged around a central ion pore, and both have a layered architecture with an extracellular region, a transmembrane channel domain, and intracellular tails. Structural comparisons show that the NMDA receptor’s extracellular region packs more tightly than the AMPA receptor’s, but elastic network modeling reveals that both receptors share similar dynamic motions. The AMPA receptor can compress toward the more tightly packed NMDA-like conformation, and these motions have been linked to allosteric regulation, meaning that how the extracellular parts move can influence whether the channel opens or stays shut.20Structure. Architecture and Dynamics of Ionotropic Glutamate Receptors The shared structural blueprint makes sense: these receptors diverged from a common ancestor, and evolution fine-tuned each one for a distinct job while preserving the basic four-subunit channel design.
The subunit composition itself drives many of the functional differences. AMPA receptors are assembled from combinations of four subunit types (GluA1 through GluA4), while NMDA receptors require two obligatory GluN1 subunits combined with two GluN2 or GluN3 subunits. The specific GluN2 variant (2A, 2B, 2C, or 2D) shapes the receptor’s sensitivity, opening duration, and magnesium-block strength, which is why different brain regions and developmental stages feature different NMDA receptor subtypes. The GluN2B-containing receptors in juvenile amygdala that preferentially drive LTD, mentioned earlier, are one example of how subunit identity translates into distinct function.8PubMed. GluN2B subunits of the NMDA receptor contribute to the AMPA receptor internalization during long-term depression in the lateral amygdala of juvenile rats
The Co-Agonist Question
One area of active research concerns the NMDA receptor’s co-agonist site and which molecule, glycine or D-serine, occupies it under normal conditions. The answer turns out to depend on where in the brain you look. D-serine is the dominant co-agonist in the forebrain, including the hippocampus and cortex, where most research on learning and memory focuses. Glycine appears to play a larger role in the brainstem and spinal cord.2PubMed Central. Differential regulation of NMDA receptors by d-serine and glycine in mammalian spinal locomotor networks D-serine is produced by a specific enzyme in astrocytes and some neurons, and its local concentration can be regulated independently of glutamate, giving the brain another dial to turn when adjusting NMDA receptor activity.
This has practical implications. If NMDA hypofunction contributes to schizophrenia, then boosting co-agonist levels is one potential therapeutic strategy. Clinical trials have tested D-serine, glycine, and compounds that raise their levels, with mixed but occasionally promising results. The regional specificity of which co-agonist matters means a drug that works on forebrain NMDA receptors via the D-serine pathway may have different effects in the spinal cord, where glycine predominates. It also means that AMPA receptors, which have no co-agonist requirement at all, are immune to this entire regulatory layer, one more way the two receptor types occupy fundamentally different functional niches.